公司概覽
業務類別 --
業務概覽 Medexus Pharmaceuticals Inc is a specialty pharmaceutical company with a powerful North American commercial platform and a growing portfolio of inventive and rare disease treatment solutions. The company's focus is on the therapeutic areasof oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology. Medexus products are generally sold in North America to wholesalers, distributors, government agencies, healthcare facilities and specialty pharmacies.
公司地址 10 King Street East, Suite 600, Toronto, ON, CAN, M5C 1C3
電話號碼 +1 514 762-2626
傳真號碼 +1 514 762-2336
公司網頁 https://www.medexus.com
員工數量 91
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Richard Labelle Chief Operating Officer -- 25/06/2025
Mr. Kenneth d’Entremont Chief Executive Officer and Director -- 15/08/2025
Mr. Brendon Buschman Chief Financial Officer -- 15/08/2025
Mr. Ian C Wildgoose Brown General Counsel and Corporate Secretary -- 15/08/2025
 
董事會成員
董事會 職務 更新日期
Ms. Nancy R. Phelan Independent Director 15/08/2025
Mr. Michael Mueller Chairman of the Board 15/08/2025
Mr. Benoit Gravel Independent Director 15/08/2025
Mr. Kenneth d’Entremont Chief Executive Officer and Director 15/08/2025
Mr. Stephen Nelson Independent Director 15/08/2025
Dr. Harmony P. Garges, M.D. Independent Director 15/08/2025
Mr. Menassie Taddese, M.B.A. Independent Director 15/08/2025
 
所屬ETF (更新日期: 07/03/2026 04:07)
代號 名稱 佔比% 持有日期
DFICDimensional International Core Eq 2 ETF0.08%27/02/2026
DFAXDimensional World ex US Core Eq 2 ETF0.02%27/02/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.